ExpreS2ion Biotech (Sweden) Top Management

EXPRS2 Stock  SEK 30.60  0.60  2.00%   
ExpreS2ion Biotech employs about 14 people. The company is managed by 6 executives with a total tenure of roughly 33 years, averaging almost 5.0 years of service per executive, having 2.33 employees per reported executive. Analysis of ExpreS2ion Biotech's management performance can provide insight into the company performance.
Keith Alexander  Insider
Chief Officer
Lars Petersen  Insider
Medical Oncology
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ExpreS2ion Biotech Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

ExpreS2ion Biotech Management Team Effectiveness

The company has return on total asset (ROA) of (0.5513) % which means that it has lost $0.5513 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9735) %, meaning that it generated substantial loss on money invested by shareholders. ExpreS2ion Biotech's management efficiency ratios could be used to measure how well ExpreS2ion Biotech manages its routine affairs as well as how well it operates its assets and liabilities.

ExpreS2ion Biotech Workforce Comparison

ExpreS2ion Biotech Holding is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 1,242. ExpreS2ion Biotech claims roughly 14.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.

ExpreS2ion Biotech Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. ExpreS2ion Biotech Price Series Summation is a cross summation of ExpreS2ion Biotech price series and its benchmark/peer.

ExpreS2ion Biotech Notable Stakeholders

An ExpreS2ion Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ExpreS2ion Biotech often face trade-offs trying to please all of them. ExpreS2ion Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ExpreS2ion Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About ExpreS2ion Biotech Management Performance

The success or failure of an entity such as ExpreS2ion Biotech often depends on how effective the management is. ExpreS2ion Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ExpreS2ion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ExpreS2ion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. ExpreS2ion Biotech operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 15 people.
Please note, the presentation of ExpreS2ion Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ExpreS2ion Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ExpreS2ion Biotech's management manipulating its earnings.

ExpreS2ion Biotech Workforce Analysis

Traditionally, organizations such as ExpreS2ion Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ExpreS2ion Biotech within its industry.

ExpreS2ion Biotech Manpower Efficiency

Return on ExpreS2ion Biotech Manpower

Revenue Per Employee873.9K
Revenue Per Executive2M
Net Loss Per Employee3.1M
Net Loss Per Executive7.3M

Complementary Tools for ExpreS2ion Stock analysis

When running ExpreS2ion Biotech's price analysis, check to measure ExpreS2ion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ExpreS2ion Biotech is operating at the current time. Most of ExpreS2ion Biotech's value examination focuses on studying past and present price action to predict the probability of ExpreS2ion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ExpreS2ion Biotech's price. Additionally, you may evaluate how the addition of ExpreS2ion Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas